Record Details

Circulating Carboxy-Terminal Propeptide of type I Procollagen is Increased in Rheumatic Heart Disease

EPrints@IICB

View Archive Info
 
 
Field Value
 
Title Circulating Carboxy-Terminal Propeptide of type I Procollagen is Increased in Rheumatic Heart Disease
 
Creator Banerjee, Tanima
Mukherjee, Somaditya
Biswas, Monodeep
Dutta, Santanu
Chatterjee, Shelly
Ghosh, Sudip
Pattari, Sanjib
Nanda, Navin C
Bandyopadhyay, Arun
 
Subject Cell Biology & Physiology
 
Description Mitral valve is mostly affected in rheumatic heart disease which is
prevalent in developing countries [1–3] and thousands of new cases
are being diagnosed worldwide every year [1–3]. It is known that
extensive fibrosis occurs in the rheumatic valve [4]. Serum carboxyterminal
propeptide of type I procollagen (PICP), the marker of
collagen synthesis was reported as a marker of extracellular matrix
(ECM) remodelling in various heart diseases [5–8]. We therefore,
measured the levels of circulating PICP to explore the severity of ECM
remodelling in rheumatic heart disease.
 
Publisher Elsevier
 
Date 2012
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/1512/1/INTERNATIONAL_JOURNAL_OF_CARDIOLOGY___156(_1)_117%2D119;2012[19].pdf
Banerjee, Tanima and Mukherjee, Somaditya and Biswas, Monodeep and Dutta, Santanu and Chatterjee, Shelly and Ghosh, Sudip and Pattari, Sanjib and Nanda, Navin C and Bandyopadhyay, Arun (2012) Circulating Carboxy-Terminal Propeptide of type I Procollagen is Increased in Rheumatic Heart Disease. International Journal of Cardiology, 156 (1). pp. 117-119.
 
Relation http://dx.doi.org/10.1016/j.ijcard.2012.01.026
http://www.eprints.iicb.res.in/1512/